cannabinoids drug

Aliases

THC, cannabinoid receptors, cannabinoids, delta-9-tetrahydrocannabinol, endogenous cannabinoid, marijuana, natural cannabinoids, naturally occurring cannabinoids, synthetic cannabinoids

External links

DrugBank · PubChem

Related entities (59)

Mentioned in (59)

Papers in which this entity is mentioned.

• Gene-alcohol interactions in birth defects. (2023)
• Fetal Alcohol Spectrum Disorders: Awareness to Insight in Just 50 Years. (2022)
• Multifactorial Genetic and Environmental Hedgehog Pathway Disruption Sensitizes Embryos to Alcohol-Induced Craniofacial Defects. (2020)
• Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
• Cannabinoids Exacerbate Alcohol Teratogenesis by a CB1-Hedgehog Interaction. (2019)
• Cannabis Teratology Explains Current Patterns of Coloradan Congenital Defects: The Contribution of Increased Cannabinoid Exposure to Rising Teratological Trends. (2019)
• A randomized controlled trial of screening and brief interventions for substance misuse in reproductive health. (2018)
• Diagnosis and Pharmacotherapy of Alcohol Use Disorder: A Review. (2018)
• The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
• An Update on Non-CB, Non-CB Cannabinoid Related G-Protein-Coupled Receptors. (2017)
• The acute effect of cannabis on plasma, liver and brain ammonia dynamics, a translational study. (2017)
• Functional Connectivity of the Infant Human Brain: Plastic and Modifiable. (2017)
• Marijuana Use During Stages of Pregnancy in the United States. (2017)
• Prenatal ethanol exposure in mice phenocopies Cdon mutation by impeding Shh function in the etiology of optic nerve hypoplasia. (2017)
• Genome-wide Association Study of Cannabis Dependence Severity, Novel Risk Variants, and Shared Genetic Risks. (2016)
• Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States. (2016)
• CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function. (2016)
• Alcohol Use During Pregnancy is Associated with Specific Alterations in MicroRNA Levels in Maternal Serum. (2016)
• Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice. (2016)
• Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
• Functional Connectivity Disruption in Neonates with Prenatal Marijuana Exposure. (2015)
• Endocannabinoids are conserved inhibitors of the Hedgehog pathway. (2015)
• Dissecting impulsivity and its relationships to drug addictions. (2014)
• Heritability and molecular-genetic basis of the P3 event-related brain potential: a genome-wide association study. (2014)
• Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
• Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? (2014)
• Effects of Acute Prenatal Exposure to Ethanol on microRNA Expression are Ameliorated by Social Enrichment. (2014)
• Neuronal substrates and functional consequences of prenatal cannabis exposure. (2014)
• Heritability and molecular-genetic basis of resting EEG activity: a genome-wide association study. (2014)
• Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. (2014)
• Moving around the molecule: relationship between chemical structure and in vivo activity of synthetic cannabinoids. (2014)
• The impact of exposure to addictive drugs on future generations: Physiological and behavioral effects. (2014)
• Baths salts, spice, and related designer drugs: the science behind the headlines. (2014)
• A survey of synthetic cannabinoid consumption by current cannabis users. (2014)
• Neurodevelopmental alcohol exposure elicits long-term changes to gene expression that alter distinct molecular pathways dependent on timing of exposure. (2013)
• Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
• Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. (2012)
• The co-occurring use and misuse of cannabis and tobacco: a review. (2012)
• Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety. (2012)
• Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
• Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications. (2011)
• Response to alcohol in women: role of the menstrual cycle and a family history of alcoholism. (2011)
• AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. (2011)
• Pharmacological treatment of cannabis dependence. (2011)
• Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. (2011)
• Adolescent initiation of licit and illicit substance use: Impact of intrauterine exposures and post-natal exposure to violence. (2011)
• Association study of 182 candidate genes in anorexia nervosa. (2010)
• Neurobiology of the adolescent brain and behavior: implications for substance use disorders. (2010)
• International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂. (2010)
• Cannabis and psychosis/schizophrenia: human studies. (2009)
• Hippocampal CB(1) receptors mediate the memory impairing effects of Delta(9)-tetrahydrocannabinol. (2009)
• Brain stress systems in the amygdala and addiction. (2009)
• Neuroimaging of children following prenatal drug exposure. (2009)
• Neuroimaging of children following prenatal drug exposure. (2009)
• Protein kinases and addiction. (2008)
• EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. (2008)
• Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
• Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
• Cerebellar cortex lesions disrupt learning-dependent timing of conditioned eyelid responses. (1993)

Merged raw entities (6)

All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.